| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |